Imaging helps predict head and neck cancer survival

04/4/2013 | AuntMinnie.com (free registration)

A study published in the Journal of Nuclear Medicine found that in patients with head and neck cancer undergoing initial radiotherapy or chemoradiotherapy, a drop of at least 45% in the maximum standardized uptake value on FLT-PET/CT scans and a decrease of at least 31% in gross tumor volume measured using visual delineation were linked with a three-year disease-free survival rate of 88%. Three-year disease-free survival was 63% for other patients. Scans undertaken in the second week of therapy were the most useful in customizing treatment, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC